|
LARGE expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.767400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.395800E-01 |
| Normal-vs-Stage2 |
9.464400E-01 |
| Normal-vs-Stage3 |
8.238800E-01 |
| Normal-vs-Stage4 |
5.954000E-01 |
| Stage1-vs-Stage2 |
8.486200E-01 |
| Stage1-vs-Stage3 |
7.536400E-01 |
| Stage1-vs-Stage4 |
3.105200E-01 |
| Stage2-vs-Stage3 |
7.235000E-01 |
| Stage2-vs-Stage4 |
6.037400E-01 |
| Stage3-vs-Stage4 |
2.507600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.134600E-01 |
| Normal-vs-AfricanAmerican |
5.078800E-01 |
| Normal-vs-Asian |
7.801400E-01 |
| Caucasian-vs-AfricanAmerican |
3.682600E-01 |
| Caucasian-vs-Asian |
4.087800E-01 |
| AfricanAmerican-vs-Asian |
2.078800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.494200E-01 |
| Normal-vs-Female |
8.704400E-01 |
| Male-vs-Female |
2.852600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.656600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.595000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.432200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.508600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.336800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.650600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.291600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.648200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.271000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.620600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.328440E-01 |
| Classical-VS-Follicular |
9.785600E-02 |
| Classical-VS-Other |
6.064300E-02 |
| Classical-VS-Normal |
7.802000E-01 |
| Tall-VS-Follicular |
1.330210E-02 |
| Tall-VS-Other |
9.998800E-03 |
| Tall-VS-Normal |
2.279400E-01 |
| Follicular-VS-Other |
4.272400E-01 |
| Follicular-VS-Normal |
4.621000E-01 |
| Other-VS-Normal |
3.383400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.108400E-01 |
| Normal-vs-N1 |
6.522800E-01 |
| N0-vs-N1 |
8.379000E-01 |
|
|
